Elite Pharmaceuticals, Inc. (ELTP) Investment Research Dashboard
About Elite Pharmaceuticals, Inc. (ELTP) stock analysis
Get live ELTP stock price $0.38, comprehensive Elite Pharmaceuticals, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ELTP stock data and investment insights.
Loading chart data...
Elite Pharmaceuticals, Inc. (ELTP) Overview
Elite Pharmaceuticals, Inc. (ELTP) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, ELTP trades at $0.38 with a market capitalization of 403.91M . Over the past 52 weeks, ELTP has traded between $0.33 and $0.74 , with the current price positioned at approximately 11% of this rang...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 403.91M
- Current price: $0.38
- 52-week range: $0.33 - $0.74
- P/E ratio: 13.79
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Elite Pharmaceuticals, Inc. (ELTP) is a specialized pharmaceutical company focused on the creation and manufacturing of generic medications, as well as oral, controlled-release drug formulations. Its business activities are primarily divided into two...
Company Information
- CEO
- Nasrat Hakim
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 65
Contact Information
- Website
- https://www.elitepharma.com
- Address
- 165 Ludlow Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 13.8)
✓ Lower volatility stock (Beta: 0.38) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Elite Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Elite Pharmaceuticals, Inc.
- ⚠Investors should consider how Elite Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
403.91M
P/E Ratio (TTM)
13.79
Beta
0.38
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ELTP with peer companies:
- Price
- $1.12+0.00% (1D)
- Market cap
- 82.04M
- Price
- $0.15+0.00% (1D)
- Market cap
- 756.30M
- Price
- $31.50+0.00% (1D)
- Market cap
- 546.91M
- Price
- $60.28+0.00% (1D)
- Market cap
- 746.00M
- Price
- $0.00+0.00% (1D)
- Market cap
- 97.18K
- Price
- $10.79+0.00% (1D)
- Market cap
- 851.77M
- Price
- $0.00+0.00% (1D)
- Market cap
- 1.71K
- Price
- $3.05-2.56% (1D)
- Market cap
- 487.51M
- Price
- $24.57-100.00% (1D)
- Market cap
- 690.70M
- Price
- $0.55+0.00% (1D)
- Market cap
- 643.13M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.